A potential underlying mechanism for the FcγRIIB dysregulation is a functionally relevant single nucleotide polymorphism in the FcγRIIB promoter, i.e., previously reported as being associated with systemic lupus erythematosus in humans and is significantly enriched in CIDP patients [27]. This evidence concerns the gene FCGR2B and chronic inflammatory demyelinating polyradiculoneuropathy.